Sheppard, J., & Singh, I. (2019). Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery. Clin Ophthalmol.
Stile di citazione ChicagoSheppard, JD, e IP Singh. "Real World Use of Loteprednol Etabonate Ophthalmic Gel 0.5% in Cases Representative of Comorbid Pathologies Responding to Minimally Invasive Glaucoma Surgery." Clin Ophthalmol 2019.
Citazione MLASheppard, JD, e IP Singh. "Real World Use of Loteprednol Etabonate Ophthalmic Gel 0.5% in Cases Representative of Comorbid Pathologies Responding to Minimally Invasive Glaucoma Surgery." Clin Ophthalmol 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.